OCM
BMY icon

Orleans Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Orleans Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,721
Closed -$755K – 78
2023
Q4 		$755K Sell
14,721
-16,222
-52% -$852K 0.51% 47
2023
Q3 		$1.8M Sell
30,943
-1,465
-5% -$89.8K 1.33% 31
2023
Q2 		$2.07M Sell
32,408
-490
-1% -$32.9K 1.47% 27
2023
Q1 		$2.28M Buy
32,898
+50
+0.2% +$3.53K 1.68% 25
2022
Q4 		$2.36M Buy
32,848
+1,015
+3% +$76.5K 1.81% 22
2022
Q3 		$2.26M Sell
31,833
-150
-0.5% -$10.9K 1.89% 22
2022
Q2 		$2.46M Buy
31,983
+935
+3% +$71.2K 1.84% 23
2022
Q1 		$2.27M Buy
31,048
+10,450
+51% +$702K 1.41% 28
2021
Q4 		$1.28M Sell
20,598
-8,692
-30% -$510K 0.73% 40
2021
Q3 		$1.73M Sell
29,290
-165
-0.6% -$10.9K 1.11% 33
2021
Q2 		$1.97M Sell
29,455
-400
-1% -$26.1K 1.26% 35
2021
Q1 		$1.89M Buy
29,855
+6,000
+25% +$373K 1.28% 33
2020
Q4 		$1.48M Sell
23,855
-9,690
-29% -$596K 1.06% 31
2020
Q3 		$2.02M Sell
33,545
-150
-0.4% -$9.03K 1.54% 29
2020
Q2 		$1.98M Buy
+33,695
New +$2.02M 1.62% 25
2014
Q4 		– Sell
-4,650
Closed -$238K – 93
2014
Q3 		$238K Sell
4,650
-83,819
-95% -$4.19M 0.12% 92
2014
Q2 		$4.29M Buy
88,469
+1,140
+1% +$56.2K 2.01% 8
2014
Q1 		$4.54M Sell
87,329
-1,296
-1% -$69K 2.31% 5
2013
Q4 		$4.71M Sell
88,625
-877
-1% -$44.7K 2.44% 3
2013
Q3 		$4.14M Sell
89,502
-8,447
-9% -$371K 2.25% 3
2013
Q2 		$4.38M Buy
+97,949
New +$4.25M 2.47% 3

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Orleans Capital Management's BMY Position: Q1 2024 in Review

Orleans Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 14,721 shares — an estimated $755K sold.

Orleans Capital Management first reported a position in BMY in Q2 2013 and held it in 21 quarters. The position peaked at $4.71M in Q4 2013. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Orleans Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Orleans Capital Management sold 14,721 Bristol-Myers Squibb shares in Q1 2024, an estimated $755K.
  • Orleans Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 21 quarters.
  • Orleans Capital Management's Bristol-Myers Squibb position peaked at $4.71M in Q4 2013.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Orleans Capital Management's 13F filing for Q1 2024, filed 22 May 2024.